|
Registrations for this event have gone well. We are now nearly sold out.
To network with the Japan’s leading marketing experts, REGISTER NOW without delay.
Fonny Schenck (J&J)
About CRM
Increased regulation, generics and price restraints are reducing the number of innovative drugs in the pipeline. Marketing departments have to switch their attention from promoting new products to finding cost-effective ways to dominate segments of the market. This requires the total command of market intelligence and clinical data, the ability to identify patients and physicians in target segments and the skill to deliver relevant and compelling information.
A few confirmed speakers include:
Mr M. Aoi, Professor, Graduate School of Business Administration, Keio University
Mr P. Auvaro, Sales Division, Deputy Director and Head of Administration & Planning Bumon, GlaxoSmithKline
Dr A. K. Bates, President, Eularis
Ms K. Fujikawa, Director Marketing Research & Business Intelligence, Pfizer Japan Inc.
Mr Y. Guochao, Associate General Manager, MedMed Group
Mr H. Hatanaka, Senior Analyst, CareNet, Inc.
Mr T. Hirata, Director, Product and Portfolio Strategy, Astellas Pharma Inc.
Mr T. Ichihara, Director, Product Marketing Department, Kowa Pharmaceutical Co., Ltd.
Mr. D. Impey, Former European Director of Marketing, Eisai Europe Ltd.
Mr M. Kimura, Manager, Market Research, Marketing Division, Banyu Pharmaceutical Co., Ltd.
Dr P. Keohane, Executive Officer, Vice President and Head, Japan Research and Development, AstraZeneca K.K.
Mr D. Kim, Head of Global Business, Connect & Development, Daewoong Pharmaceutical Co.
Mr. R. Krishnan, Vice President – Product Strategy, Oracle Corporation
Mr N. Kumazawa, Department Manager, Customer Care Center, GlaxoSmithKline K.K.
Mr. H. Nagl, Senior Manager, Global Business Insights and Commercial Operations, Shire USA
Mr. H. Nakamura, Graduate School of Business Administration, Keio University, Professor
Mr T Shozen, Head of Organization & Information Japan / Korea, BHC Central Administration & Organization, Bayer Yakuhin, Ltd.
Mr E. Shu, Vice President, Management Consulting, Consulting & Services, IMS Japan K.K
Mr Y. Sonoda, Manager, International Business Department, Daiichi Sankyo Co,LTD.
Mr S. Tanto, Head of Corporate Strategy, BDL, Alliance Management and Strategic Marketing Division, UCB Japan
Mr M. Toriyama, Senior Consultant、Service Industry Consulting Department、Nomura Research Institute
…20 Speakers confirmed, with more to come!
Download the brochure
The topics below will be covered at our unique conference:
BETTER LIFECYCLE MANAGEMENT: Find out how to choose the marketing routes that generate maximum profit from every drug you produce – at every stage of its existence
LUCRATIVE WAYS TO MONITOR, MEASURE AND ASSESS YOUR MARKETING STRATEGY: Use ROI analysis to devise strategies that secure increased profits and improved shareholder value
NEW WAYS TO INNOVATE: Learn what role marketing should have in the Research and Development process
MARKET RESEARCH: How to identify those segments of the market where the brand has a competitive advantage and dominate them
INTERNATIONAL PERSPECTIVE: Discover what is happening in the other territories; the USA, European, Chinese and Korean markets – and how you can apply these strategies immediately
REACH YOUR KEY CUSTOMERS: Re-discover who your customers really are, what they want from you and what messages work for them so that you sell more of your product and beat the competition
The above topics will be covered at our unique conference.
Please send your ideas, suggestions, proposals to Takuya Shimada on tshimada@eyeforpharma.com (or +44 207 375 7154 / +1 800 814 3459 x212) or click here to be kept informed about this event.
|
